Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ANVS compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
ANVS
Annovis Bio, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
ANVS
Annovis Bio, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ANVS
1
—
Alzheimer's Disease Cooperative Study ("ADCS")
unlisted
supplier
Shared
0
No shared counterparties.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
25 more · LLY chain
›
ANVS
Annovis Bio, Inc.
Change
1.14
· pre 1.15
Mkt cap
$48.1M
Revenue
—
Revenue
—
LLY
ELI Lilly & Co
Change
1,412.87
· pre 1,419.05
Pre-market
Sep 2 '83
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Pre-market
Sep 2 '83
ANVS
Annovis Bio, Inc.
vs
LLY
ELI Lilly & Co
1.14
pre 1.15
Price
1,412.87
pre 1,419.05
$48.1M
Mkt cap
$1.3T
—
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
ANVS
1.14
vs
LLY
1,412.87
Pre-market
Sep 2 '83